1-(6-Bromo-5-hydroxyindolin-1-yl)ethanone, 97%, 250mg

3-Methyl-thiophene-2-carbonyl chloride, 95.0%, 5g

(2-furylmethyl)(2-pyridinylmethyl)amine oxalate, 95.0%, 10g

Nicotinic Acid [Matrix for MALDI-TOF/MS]>99.5%(HPLC)(T)5g

Ethyl 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate, 97.0%, 1g

2,4-Dichloro-6,7-dihydro-5H-cyclopenta[b]pyridine hydrochloride, 95+%, 100mg

3-BROMO-4-FLUOROBENZAMIDINE HCL, 95.0%, 250mg

3-BROMO-4-(DIFLUOROMETHYL)ANISOLE, 95.0%, 10g

tert-Butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95%, 250mg

3-METHYLBENZO[D]ISOXAZOLE-5-CARBOXYLIC ACID, 95%, 250mg

3,5-Dibromo-2-hydroxy-N-(4-methoxy-phenyl)-benzamide, 95.0%, 1g

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 250mg

(1S,2R)-1-(6-BROMO-2-METHOXYQUINOLIN-3-YL)-4-(DIMETHYLAMINO)-2-(NAPHTHALEN-1-YL)-1-PHENYLBUTAN-2-OL, 98%, 1g